Recently, the Hefei Science and Technology Bureau of Anhui Province announced the proposed list of “New Technologies, New Products, and New Models in Hefei for 2024.” After rounds of selection, the Treprostinil Injection, a product of Zhaoke Pharmaceutical (Hefei) Company Limited (“Zhaoke Hefei”), which is a wholly-owned subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group”, stock code: 00950), was successfully recognized as a “New Product” in the biopharmaceutical industry and was included in the “New Product Promotion and Application Directory of Hefei”.
Thai 
English